6-K
IPERIONX Ltd (IPX)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
Date: December 1, 2025
Commission File Number: 001-41338
IperionX Limited
(Translation of registrant’s name into English)
129 W Trade Street, Suite 1405
Charlotte, North Carolina
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F X Form 40-F ☐
EXHIBIT INDEX
The following exhibits are filed as part of this Form 6-K:
| Exhibit | Description |
|---|---|
| 99.1 | Results of Annual General Meeting |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| IPERIONX LIMITED | ||
|---|---|---|
| (registrant) | ||
| Date: December 1, 2025 | By: | /s/ Marcela Castro |
| Name: Marcela Castro | ||
| Title: Chief Financial Officer |
Exhibit 99.1
| PRESS RELEASE | NASDAQ: IPX | ASX: IPX |
|---|---|---|
| November 28, 2025 |
RESULTS OF ANNUAL GENERAL MEETING
IperionX Limited (NASDAQ: IPX, ASX: IPX) (“IperionX” or “Company”) advises that the Company’s Annual General Meeting of Shareholders was held today, November 28, 2025, at 9.00am (AWST).
The resolutions voted on were in accordance with the Notice of Annual General Meeting previously advised to the Australian Securities Exchange (“ASX”).
All resolutions were decided on and carried by way of a poll, except for Resolution 8 (Election of Non-Board Endorsed Candidate Mr Stephen Mayne as Director), which was not carried.
In accordance with Section 251AA of the Corporations Act 2001 and ASX Listing Rule 3.13.2, the details of the poll and the proxies received in respect of each resolution are set out in the attached summary.
About IperionX
IperionX is a leading American titanium metal and critical materials company – using patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy, cost and carbon emissions.
Our Titan critical minerals project is the largest JORC Mineral Resource of titanium, rare earth and zircon minerals sands in the United States.
IperionX’s titanium metal and critical minerals are essential for advanced U.S. industries including space, aerospace, defense, consumer electronics, hydrogen, automotive and additive manufacturing.
This announcement has been authorized for release by the Company Secretary.
For further information and enquiries please contact:
+1 704 461 8000
www.iperionx.com
| North Carolina | Tennessee | Virginia | Utah |
|---|---|---|---|
| 129 W Trade Street, Suite 1405<br><br> <br>Charlotte, NC 28202 | 279 West Main Street<br><br> <br>Camden, TN 38320 | 1080 Confroy Drive<br><br> <br>South Boston, VA 24592 | 1782 W 2300 S<br><br> <br>West Valley City, UT 84119 |
| Forward<br> Looking Statements<br><br> <br>Information included in this release constitutes forward-looking statements. Often, but not always, forward looking statements can generally be identified by the<br> use of forward-looking words such as “may”, “will”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “continue”, and “guidance”, or other similar words and may include, without limitation, statements regarding plans, strategies and<br> objectives of management, anticipated production or construction commencement dates and expected costs or production outputs.<br><br> <br><br><br> <br>Forward looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance,<br> and achievements to differ materially from any future results, performance, or achievements. Relevant factors may include, but are not limited to, changes in commodity prices, foreign exchange fluctuations and general economic conditions,<br> increased costs and demand for production inputs, the speculative nature of exploration and project development, including the risks of obtaining necessary licenses and permits and diminishing quantities or grades of reserves, the Company’s<br> ability to comply with the relevant contractual terms to access the technologies, commercially scale its closed-loop titanium production processes, or protect its intellectual property rights, political and social risks, changes to the<br> regulatory framework within which the Company operates or may in the future operate, environmental conditions including extreme weather conditions, recruitment and retention of personnel, industrial relations issues and litigation.<br><br> <br><br><br> <br>Forward looking statements are based on the Company and its management’s good faith assumptions relating to the financial, market, regulatory and other relevant<br> environments that will exist and affect the Company’s business and operations in the future. The Company does not give any assurance that the assumptions on which forward looking statements are based will prove to be correct, or that the<br> Company’s business or operations will not be affected in any material manner by these or other factors not foreseen or foreseeable by the Company or management or beyond the Company’s control.<br><br> <br>Although<br> the Company attempts and has attempted to identify factors that would cause actual actions, events or results to differ materially from those disclosed in forward looking statements, there may be other factors that could cause actual results,<br> performance, achievements, or events not to be as anticipated, estimated or intended, and many events are beyond the reasonable control of the Company. Accordingly, readers are cautioned not to place undue reliance on forward looking<br> statements. Forward looking statements in these materials speak only at the date of issue. Subject to any continuing obligations under applicable law or any relevant stock exchange listing rules, in providing this information the Company does<br> not undertake any obligation to publicly update or revise any of the forward-looking statements or to advise of any change in events, conditions or circumstances on which any such statement is based. |
|---|
IperionX Limited
Annual General Meeting
November 28, 2025
| Resolution | Number of Proxy Votes | Number of Votes cast on the Poll | Result | |||||
|---|---|---|---|---|---|---|---|---|
| For | Against | Abstain | Proxy’s Discretion | For | Against | Abstain | ||
| 1. Remuneration Report | 107,229,812 | 17,938,535 | 39,285,578 | 5,231,266 | 112,503,079<br><br> <br>(86.25%) | 17,938,535<br><br> <br>(13.75%) | 39,285,578 | Carried |
| 2. Re-election of Mr Todd Hannigan as Director | 159,906,402 | 4,541,673 | 5,850 | 5,231,266 | 165,179,669<br><br> <br>(97.32%) | 4,541,673<br><br> <br>(2.68%) | 5,850 | Carried |
| 3. Re-election of Ms Beverly Wyse as Director | 162,383,465 | 2,043,570 | 26,890 | 5,231,266 | 167,656,732<br><br> <br>(98.80%) | 2,043,570<br><br> <br>(1.20%) | 26,890 | Carried |
| 4. Re-election of Ms Melissa Waller as Director | 163,992,030 | 429,005 | 32,890 | 5,231,266 | 169,265,297<br><br> <br>(99.75%) | 429,005<br><br> <br>(0.25%) | 32,890 | Carried |
| 5. Re-election of Mr Vaughn Taylor as Director | 161,562,564 | 2,864,471 | 26,890 | 5,231,266 | 166,835,831<br><br> <br>(98.31%) | 2,864,471<br><br> <br>(1.69%) | 26,890 | Carried |
| 6. Re-election of Ms Lorraine Martin as Director | 164,088,698 | 338,337 | 26,890 | 5,231,266 | 169,361,965<br><br> <br>(99.80%) | 338,337<br><br> <br>(0.20%) | 26,890 | Carried |
| 7. Election of Mr Tony Tripeny as Director | 164,354,392 | 66,174 | 30,121 | 5,234,504 | 169,630,897<br><br> <br>(99.96%) | 66,174<br><br> <br>(0.04%) | 30,121 | Carried |
| 8. Election of Non-Board Endorsed Candidate Mr Stephen Mayne as Director | 7,969,430 | 156,407,570 | 84,136 | 5,224,016 | 7,969,430<br><br> <br>(4.70%) | 161,673,587<br><br> <br>(95.30%) | 84,136 | Not carried |
| 9. Issue of RSUs to Non-Executive Director – Ms Lorraine Martin | 153,769,328 | 9,654,129 | 1,027,230 | 5,234,504 | 159,045,833<br><br> <br>(94.28%) | 9,654,129<br><br> <br>(5.72%) | 1,027,230 | Carried |
| 10. Issue of RSUs to Non-Executive Director – Mr Vaughn Taylor | 154,756,057 | 9,655,159 | 39,471 | 5,234,504 | 160,032,562<br><br> <br>(94.31%) | 9,655,159<br><br> <br>(5.69%) | 39,471 | Carried |
| 11. Issue of RSUs to Non-Executive Director – Ms Melissa Waller | 154,750,917 | 9,660,299 | 39,471 | 5,234,504 | 160,027,422<br><br> <br>(94.31%) | 9,660,299<br><br> <br>(5.69%) | 39,471 | Carried |
| 12. Issue of RSUs to Non-Executive Director – Ms Beverly Wyse | 154,196,378 | 9,658,349 | 595,960 | 5,234,504 | 159,472,883<br><br> <br>(94.29%) | 9,658,349<br><br> <br>(5.71%) | 595,960 | Carried |
| 13. Issue of RSUs to Non-Executive Director Mr Tony Tripeny | 154,731,012 | 9,655,589 | 64,086 | 5,234,504 | 160,007,517<br><br> <br>(94.31%) | 9,655,589<br><br> <br>(5.69%) | 64,086 | Carried |